ORCHID PHARMA
Back to Income Statement
|
ORCHID PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹100 Cr | ₹92 Cr | ₹46 Cr | ₹-1.95 Cr | ₹-117 Cr |
What is the latest Consolidated Net Profit of ORCHID PHARMA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹100 Cr |
| Mar2024 | ₹92 Cr |
| Mar2023 | ₹46 Cr |
| Mar2022 | ₹-1.95 Cr |
| Mar2021 | ₹-117 Cr |
How is Consolidated Net Profit of ORCHID PHARMA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹100 Cr | 8.13 | |
| Mar2024 | ₹92 Cr | 98.99 | |
| Mar2023 | ₹46 Cr | Positive | |
| Mar2022 | ₹-1.95 Cr | Negative | |
| Mar2021 | ₹-117 Cr | - | |
Compare Consolidated Net Profit of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹2,660.0 Cr | -2.5% | -24.4% | -44.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,855.0 Cr | 2.4% | 7.1% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,550.0 Cr | -0.2% | 3.8% | 15.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,906.0 Cr | 1.8% | 10.9% | 48.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,632.0 Cr | 1% | 4% | 16.6% | Stock Analytics | |
| CIPLA | ₹107,427.0 Cr | 0.3% | -0.9% | -6% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | -2.5% |
-24.4% |
-44.3% |
| SENSEX | -2.9% |
-8% |
5.3% |
You may also like the below Video Courses